Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram

Showing results (561-570 of 8,441) with videos related to

Pageof 845
Sort By:
Circulation|April 23, 2021
Does SGLT1 Inhibition Add Benefit to SGLT2 Inhibition in Type 2 Diabetes?Bertram Pitt, Deepak L Bhatt
Journal of Cardiovascular Pharmacology|September 1, 2023
Statins in Patients With Established Heart Failure: Time for ReflectionBertram Pitt, Robert S Rosenson
JACC. Heart Failure|September 28, 2023
1+2 Might Be >2: SGLT Inhibition in Patients With Heart Failure or Chronic Kidney DiseaseBertram Pitt, Deepak L Bhatt
Foods (Basel, Switzerland)|September 9, 2022
NMR-Based Metabolomics to Decipher the Molecular Mechanisms in the Action of Gut-Modulating FoodsWeiwei He, Hanne Christine Bertram
Der Pathologe|September 23, 2020
[Fluorescence in situ hybridization for the diagnosis of soft-tissue and bone tumors]Stefanie Bertram, Hans-Ulrich Schildhaus
Hypertension (Dallas, Tex. : 1979)|August 26, 2015
New potassium binders for the treatment of hyperkalemia: current data and opportunities for the futureBertram Pitt, George L Bakris
Ecology|December 24, 2013
Statistical patterns in tropical tree cover explained by the different water demand of individual trees and grassesJason Bertram, Roderick C Dewar
Toxins|May 11, 2016
Toxin-Antitoxin Systems of Staphylococcus aureusChristopher F Schuster, Ralph Bertram
Journal of Visualized Experiments : Jove|November 20, 2014
Fluorescence based primer extension technique to determine transcriptional starting points and cleavage sites of RNases in vivoChristopher F Schuster, Ralph Bertram
European Journal of Heart Failure|March 2, 2018
Is hyperkalaemia in heart failure a risk factor or a risk marker? Implications for renin-angiotensin-aldosterone system inhibitor useLars H Lund, Bertram Pitt
Pageof 845

Showing results (561-570 of 8,441) with videos related to

Sort By:
Pageof 845
Circulation|April 23, 2021
Does SGLT1 Inhibition Add Benefit to SGLT2 Inhibition in Type 2 Diabetes?Bertram Pitt, Deepak L Bhatt
Journal of Cardiovascular Pharmacology|September 1, 2023
Statins in Patients With Established Heart Failure: Time for ReflectionBertram Pitt, Robert S Rosenson
JACC. Heart Failure|September 28, 2023
1+2 Might Be >2: SGLT Inhibition in Patients With Heart Failure or Chronic Kidney DiseaseBertram Pitt, Deepak L Bhatt
Foods (Basel, Switzerland)|September 9, 2022
NMR-Based Metabolomics to Decipher the Molecular Mechanisms in the Action of Gut-Modulating FoodsWeiwei He, Hanne Christine Bertram
Der Pathologe|September 23, 2020
[Fluorescence in situ hybridization for the diagnosis of soft-tissue and bone tumors]Stefanie Bertram, Hans-Ulrich Schildhaus
Hypertension (Dallas, Tex. : 1979)|August 26, 2015
New potassium binders for the treatment of hyperkalemia: current data and opportunities for the futureBertram Pitt, George L Bakris
Ecology|December 24, 2013
Statistical patterns in tropical tree cover explained by the different water demand of individual trees and grassesJason Bertram, Roderick C Dewar
Toxins|May 11, 2016
Toxin-Antitoxin Systems of Staphylococcus aureusChristopher F Schuster, Ralph Bertram
Journal of Visualized Experiments : Jove|November 20, 2014
Fluorescence based primer extension technique to determine transcriptional starting points and cleavage sites of RNases in vivoChristopher F Schuster, Ralph Bertram
European Journal of Heart Failure|March 2, 2018
Is hyperkalaemia in heart failure a risk factor or a risk marker? Implications for renin-angiotensin-aldosterone system inhibitor useLars H Lund, Bertram Pitt
Pageof 845